Concepedia

Rohini Beavon

RB

Statistics

Publications

7

Citations

139

H-Index

7

Active since

2021

Affiliations

Pfizer (United States)(Current)

Global Vaccines (United States)

North Manchester General Hospital

Rohini Beavon is an author at Pfizer (United States) specializing in infectious diseases, immunization, and pneumococcal conjugate vaccination.

Publications per year

2021–2024

7

Publications

7

LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults

Myron J. Levin, Andrew Ustianowski, Stéphane De Wit et al. · Open Forum Infectious Diseases · 2021 · 34 citations · Full text

, , +16

AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults

Yíngyún Caì, Seme Diallo, Kim Rosenthal et al. · Science Translational Medicine · 2024 · 29 citations

, , +17

Human Infection Challenge with Serotype 3 Pneumococcus

Ryan Robinson, Elena Mitsi, Elissavet Nikolaou et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 23 citations

, , +15

Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016–2018—The ECAPS study

Karin Hansen, Elisabeth Rünow, Gustav Torisson et al. · Frontiers in Public Health · 2023 · 17 citations · Full text

, , +16

Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 – April 2019

Adamantia Liapikou, Athanasios Konstantinidis, Vasiliki Kossyvaki et al. · Human Vaccines & Immunotherapeutics · 2022 · 13 citations · Full text

, , +17

1–5 of 7